fda compounding semaglutide warning letters news issues 30 to online GLP-1 compounders FDA and Novo Nordisk Warned

L., Sweeney, S., Kubik, J

Its an oral medication that you take once or twice per day

But the risks are also real, the GI burden is substantial, the long-term safety picture is incomplete, and the muscle loss concern is underappreciated

It requires daily injections

Description Additional information Description Cagrilintide (5mg) / Semaglutide (5mg) Peptide Blend Vial **Important Information: Each peptide comes lyophilized/freeze-dried and must be reconstituted with Bacteriostatic Water in order to be dispensable in liquid form

doi: 10.1073/pnas.0712185105 170 TohmeSYazdaniHOAl-KhafajiABChidiAPLoughranPMowenKet al